There have been all kinds of news about the coronavirus vaccines and potential treatments these days.
Also, not too long ago, we revealed that Fauci dropped some sad news about the disease.
New coronavirus drug looks promising
Now, it’s been reported that there’s a new drug that seems extremely promising.
The Jerusalem Post writes that some 93% of 90 coronavirus serious patients treated in several Greek hospitals with a new drug developed by a team at Tel Aviv’s Sourasky Medical Center as part of the Phase II trial of the treatment were discharged in five days or fewer.
The same online publication notes that the Phase II trial confirmed the results of Phase I, which was conducted in Israel last winter and saw 29 out of 30 patients in moderate to serious condition recover within days.
“The main goal of this study was to verify that the drug is safe,” Prof. Nadir Arber said.
He continued and said the following:
“To this day we have not registered any significant side effect in any patient from both groups.”
“It is important to remember that 19 out of 20 COVID-19 patients do not need any therapy,” Arber said.
“After a window of five to 12 days, some 5% of the patients start to deteriorate.”
Coronavirus antibodies revealed
These findings have been revealed by an analysis of samples collected after the pandemic began.
Stay tuned for more news about the new virus and make sure to stay safe.